Drug

Who makes linagliptin?

3 companies list linagliptin as a human prescription drug, including under the names Tradjenta. Forms: tablet, film coated. Routes: oral.

Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology

Companies listing linagliptin

CompanyFormsApplicationNDCsRegistered sites
Cardinal Health 418, Inc.United Statestablet, film coatedNDANDA201280134
Boehringer Ingelheim Biopharmaceuticals China LtdGermanytablet, film coatedNDANDA20128013
International Medication Systems, Ltd.United Statestablet, film coatedNDANDA20128013

Bulk ingredient listings

Orange Book patents

14 unexpired patents list linagliptin as the active ingredient, expiring between May 2027 and Dec 2037. Application holder: BOEHRINGER INGELHEIM PHARMACEUTICALS INC.

Enquiry

Common questions

Who makes linagliptin?
3 companies list linagliptin as a human prescription drug in the openFDA NDC Directory, led by Cardinal Health 418, Inc., Boehringer Ingelheim Biopharmaceuticals China Ltd, International Medication Systems, Ltd.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
Who supplies linagliptin active ingredient?
17 companies list linagliptin as a bulk ingredient, including Assia Chemical Industries Ltd. - Teva Tech Site, Aurobindo Pharma Limited, Bidachem S.p.a., Biocon Biologics Limited.